연구동향 분석

Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer

Yunxuan Wang Tieying Dong Qijia Xuan Hong Zhao Ling Qin Qingyuan Zhang 2018년

논문상세정보
    • 저자 Yunxuan Wang Tieying Dong Qijia Xuan Hong Zhao Ling Qin Qingyuan Zhang
    • 제어번호 106054572
    • 학술지명 Journal of breast cancer
    • 권호사항 Vol. 21 No. 2 [ 2018 ]
    • 발행처 한국유방암학회
    • 자료유형 학술저널
    • 수록면 124-133 ( 10쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 강원대학교 춘천캠퍼스 도서관 의학분관 경북대학교 도서관 의학분관 고려대학교 의학도서관 부산대학교 중앙도서관 영남대학교 의료원 의학도서관 충남대학교 의학도서관
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer' 의 참고문헌

  • Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer
    Teng F [2015]
  • Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers
    Denkert C [2015]
  • Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
    Matsuzaki J [2010]
  • The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
    Muenst S [2013]
  • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
    Topalian SL [2012]
  • Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
    Hamid O [2013]
  • Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
    Brahmer JR [2012]
  • Relevance of tumor-infiltrating lymphocytes in breast cancer
  • Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
    Adams S [2014]
  • Prognostic markers in triple-negative breast cancer
    Rakha EA [2007]
  • Predictive and prognostic significance of CD8(+) tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy
    Al-Saleh K [2017]
  • Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
  • Poxvirus-based active immunotherapy with PD-1 and LAG-3 dual immune checkpoint inhibition overcomes compensatory immune regulation, yielding complete tumor regression in mice
    Foy SP [2016]
  • PD-L1 Expression Is Associated with Tumor FOXP3(+) Regulatory T-Cell infiltration of breast cancer and poor prognosis of patient
    Li, Z. [2016]
  • Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
    Mesnage SJ [2017]
  • Molecular profile of tumor-specific CD8+ T cell hypofunction in a transplantable murine cancer model
    Waugh KA [2016]
  • Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy
    Symmans WF [2007]
  • Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
    Caudle AS [2012]
  • LAG-3 protein expression in non-small cell lung cancer and its relationship with PD-1/PD-L1 and tumor-infiltrating lymphocytes
    He Y [2017]
  • LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice
    Cappello P [2003]
  • Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
    Deng L [2014]
  • Inhibitory receptors as targets for cancer immunotherapy
    Turnis ME [2015]
  • Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
    Woo SR [2012]
  • Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients
    Li FJ [2013]
  • Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade
    Taube JM [2015]
  • Clinical blockade of PD1 and LAG3: potential mechanisms of action
    Nguyen LT [2015]
  • Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-kappaB to foster an immunosuppressive tumor microenvironment in ovarian cancer
    Peng J [2015]
  • CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model
    Son CH [2014]
  • An immune stratification reveals a subset of PD-1/LAG-3 doublepositive triple-negative breast cancers
    Bottai G [2016]
  • An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer
    Golden EB [2013]